Table 2 Summarize of the laboratory findings in women characterized as autoimmune patients#
From: Serologic autoimmunologic parameters in women with primary ovarian insufficiency
Antibodies | POI Women (n = 96) | Healthy women (n = 100) | P value |
|---|---|---|---|
SSA (%) | 4.2 (4/96) | 2 (2/100) | 0.322 |
Sm (%) | 0 | 0 | -- |
SCL70 (%) | 10.4 (10/96) | 6 (6/100) | 0.304 |
JO1 (%) | 10.4 (10/96) | 2 (2/100) | 0.010 |
SSB (%) | 26 (25/96) | 15 (15/100) | 0.076 |
RNP (%) | 7.3 (7/96) | 4 (4/100) | 0.366 |
CENPB (%) | 2.1 (2/96) | 2 (2/100) | 1.000 |
ANA (%) | 19.8 (19/96) | 14 (14/100) | 0.341 |
ZP | 11.5 (11/96) | 8 (8/100) | 0.474 |
ACA | 1 (1/96) | 1 (1/100) | 1.000 |
MPO | 2.1 (2/96) | 1 (1/100) | 0.615 |
PR3 | 14.6 (14/96) | 2 (2/100) | 0.001 |
TM | 8.3 (8/96) | 6 (6/100) | 0.587 |
RIBP | 10.4 (10/96) | 8 (8/100) | 0.626 |
RNPA | 8.3 (8/96) | 5 (5/100) | 0.400 |
PCNA | 3.1 (3/96) | 3 (3/100) | 1.000 |
dsDNA | 2.1 (2/96) | 0 | 0.239 |
HISTONES | 1 (1/96) | 0 | 0.490 |
GBM | 4.2 (4/96) | 3 (3/100) | 0.717 |
RF | 0 | 0 | -- |